Position in CYTK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$18,276,236
+$14,359,535 QoQ
Shares Held
214,535
+261.0% QoQ
Ownership
0.154%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#93
of 473 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRUDENTIAL FINANCIAL INC holds $555,951,804 across 189 Biotechnology names. CYTK ranks #5 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
130,659 | $81,471,112 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
133,294 | $66,211,127 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
392,811 | $22,476,644 | |
| 4 | INCY |
Incyte Corp
|
191,312 | $21,687,128 | |
| 5 | CYTK |
Cytokinetics Inc
This page
|
214,535 | $18,276,236 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
54,623 | $17,265,784 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
185,820 | $15,157,337 | |
| 8 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
2,152,154 | $13,429,440 |
All Filings in CYTK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,276,236 | 214,535 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $3,916,701 | 59,425 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $2,670,903 | 42,035 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,381,196 | 43,326 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $866,341 | 26,221 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,415,732 | 35,226 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,191,805 | 25,336 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $1,610,029 | 30,493 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,497,263 | 27,635 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,490,727 | 35,526 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $9,322,993 | 111,666 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $3,341,294 | 113,418 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,888,563 | 119,208 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,273,373 | 93,020 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $4,408,204 | 96,207 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $4,714,182 | 97,300 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $3,472,567 | 88,383 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,261,328 | 88,599 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $4,038,250 | 88,597 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,188,793 | 89,222 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,527,748 | 77,198 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,879,756 | 80,815 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $1,669,982 | 80,365 | Shares | Defined | 2021-08-16 | |
| 2020-09-30 | $2,892,548 | 133,605 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $2,191,892 | 92,995 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $1,067,938 | 90,580 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||